Please login to the form below

Not currently logged in
Email:
Password:

Intas Pharma

This page shows the latest Intas Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m

Under the terms of the deal, a chunk of Actavis' operations in the UK and Ireland will be sold to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals, for ... Accord will claim ownership of a portfolio of generic drugs as well

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Innocoll (pharma). 209. Capital International. Minority share. Intas (pharma). 106. Bain and others. ... Fingers crossed. Licensing by big pharma. The most common licensing deal is big pharma licensing in from biotech.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Red Thread

Blending brilliant writing with in-depth market access and reimbursement expertise...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....